Clinical Outcomes and Perspectives of People With Human Immunodeficiency Virus Type 1 Twelve Months After Initiation of Long-acting Cabotegravir and Rilpivirine in an Observational Real-world US Study (BEYOND)
一项观察性真实世界美国研究(BEYOND)中,接受长效卡博特韦和利匹韦林治疗 12 个月后,人类免疫缺陷病毒 1 型患者的临床结果和观点
期刊:Open Forum Infectious Diseases
影响因子:3.8
doi:10.1093/ofid/ofaf220
Dandachi, Dima; Garris, Cindy; Richardson, David; Sinclair, Gary; Cunningham, Doug; Valenti, William; Sherif, Bintu; Reynolds, Maria; Nelson, Kate; Merrill, Deanna; Schubert, Cathy; Nguyen, Kaitlin; Puga, Ana; Teichner, Paula; Zografos, Laurie